Back to User profile » Dr Sainan Li
Papers published by Dr Sainan Li:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
Liu T, Li S, Wu L, Yu Q, Li J, Feng J, Zhang J, Chen J, Zhou Y, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C
Journal of Hepatocellular Carcinoma 2020, 7:19-31
Published Date: 18 February 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways
Feng J, Chen K, Xia Y, Wu L, Li J, Li S, Wang W, Lu X, Liu T, Guo C
Drug Design, Development and Therapy 2018, 12:1837-1853
Published Date: 22 June 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Salidroside pretreatment attenuates apoptosis and autophagy during hepatic ischemia–reperfusion injury by inhibiting the mitogen-activated protein kinase pathway in mice
Feng J, Zhang Q, Mo WH, Wu L, Li S, Li J, Liu T, Xu S, Fan X, Guo C
Drug Design, Development and Therapy 2017, 11:1989-2006
Published Date: 3 July 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3
Li S, Xia Y, Chen K, Li J, Liu T, Wang F, Lu J, Zhou Y, Guo C
Drug Design, Development and Therapy 2016, 10:631-647
Published Date: 15 February 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy
Li J, Chen K, Li S, Feng J, Liu T, Wang F, Zhang R, Xu S, Zhou Y, Zhou S, Xia Y, Lu J, Zhou Y, Guo C
Drug Design, Development and Therapy 2016, 10:619-630
Published Date: 12 February 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Inhibitive effects of 15-deoxy-Δ12,14-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis
Chen K, Dai W, Wang F, Xia Y, Li J, Li S, Liu T, Zhang R, Wang J, Lu W, Zhou Y, Yin Q, Zheng Y, Abudumijiti H, Chen R, Lu J, Zhou Y, Guo C
OncoTargets and Therapy 2015, 8:3585-3593
Published Date: 1 December 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]
Yin Q, Li J, Xia Y, Zhang R, Wang J, Lu W, Zhou Y, Zheng Y, Abudumijiti H, Chen R, Chen K, Li S, Liu T, Wang F, Lu J, Zhou Y, Guo C
Drug Design, Development and Therapy 2015, 9:5947-5948
Published Date: 9 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
Yin Q, Li J, Xia Y, Zhang R, Wang J, Lu W, Zhou Y, Zheng Y, Abudumijiti H, Chen R, Chen K, Li S, Liu T, Wang F, Lu J, Zhou Y, Guo C
Drug Design, Development and Therapy 2015, 9:5407-5419
Published Date: 30 September 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis
Zhang Y, Li S, He L, Wang F, Chen K, Li J, Liu T, Zheng Y, Wang J, Lu W, Zhou Y, Yin Q, Xia Y, Zhou Y, Lu J, Guo C
Drug Design, Development and Therapy 2015, 9:2757-2766
Published Date: 25 May 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis
Zhang H, Yang J, Zhu R, Zheng Y, Zhou Y, Dai W, Wang F, Chen K, Li J, Wang C, Li S, Liu T, Abudumijiti H, Zhou Z, Wang J, Lu W, Wang J, Xia Y, Zhou Y, Lu J, Guo C
Drug Design, Development and Therapy 2015, 9:567-574
Published Date: 17 January 2015